Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA in Breast Cancer Survivors
NCT01849250Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docosahexaenoic acid in breast cancer, sponsored by National Cancer Institute. Started May 2013; status: completed.
02
Drugs
docosahexaenoic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01849250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849250.